Companies To Watch

  1. Companies To Watch: iTolerance 11/1/2022

    iTolerance is dedicated to curing diabetes and other conditions by inducing local immune tolerance in implantation.

  2. Companies To Watch: CytoAgents 10/3/2022

    CytoAgents is combatting the broad areas of disease stemming from a common cause: cytokine release syndrome.

  3. Companies To Watch: Viking Therapeutics 9/1/2022

    Viking Therapeutics is a broad-target contender for treating NASH in a pipeline of new drugs for metabolic and endocrine disorders.

  4. Companies To Watch: Priothera 8/1/2022

    Priothera is bent on boosting the safety and effectiveness of hematopoietic stem cell transplantation for blood cancers.

  5. Companies To Watch: Mirum Pharmaceuticals 7/1/2022

    Mirum Pharmaceuticals: Two drugs, one FDA approved, together taking on a half-dozen rare liver diseases.

  6. Companies To Watch: CinCor Pharma 6/1/2022

    CinCor Pharma is uncovering a great potential for combatting treatment-resistant and uncontrolled hypertension.

  7. Companies To Watch: Castle Creek Biosciences 5/2/2022

    For Castle Creek Biosciences, there are many stakes at play in targeting rare skin, connective tissue, liver, and metabolic disorders.

  8. Companies To Watch: Global Blood Therapeutics 4/1/2022

    Global Blood Therapeutics is intertwining science, business, and social missions to make progress against sickle cell disease.

  9. Companies To Watch: Endevica Bio 3/1/2022

    Endevica Bio is developing a new treatment for cachexia, a severe wasting disease critical to patients’ survival in cancer and other conditions.

  10. Companies To Watch: MiroBio 2/1/2022

    MiroBio is precisely targeting checkpoint receptors with agonist antibodies for better treatments in autoimmunity.